Sompo Japan Nipponkoa Asset Management CO. LTD. Purchases 11,740 Shares of Walgreens Boots Alliance Inc (WBA)

Sompo Japan Nipponkoa Asset Management CO. LTD. raised its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 12.2% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 107,790 shares of the pharmacy operator’s stock after acquiring an additional 11,740 shares during the period. Walgreens Boots Alliance comprises approximately 1.6% of Sompo Japan Nipponkoa Asset Management CO. LTD.’s holdings, making the stock its 21st largest holding. Sompo Japan Nipponkoa Asset Management CO. LTD.’s holdings in Walgreens Boots Alliance were worth $7,858,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. grew its stake in shares of Walgreens Boots Alliance by 1.5% in the 2nd quarter. BlackRock Inc. now owns 53,148,612 shares of the pharmacy operator’s stock valued at $3,189,715,000 after purchasing an additional 771,307 shares during the period. Caisse DE Depot ET Placement DU Quebec grew its stake in shares of Walgreens Boots Alliance by 11.5% in the 2nd quarter. Caisse DE Depot ET Placement DU Quebec now owns 11,110,617 shares of the pharmacy operator’s stock valued at $666,804,000 after purchasing an additional 1,143,819 shares during the period. Northern Trust Corp grew its stake in shares of Walgreens Boots Alliance by 1.9% in the 2nd quarter. Northern Trust Corp now owns 11,102,159 shares of the pharmacy operator’s stock valued at $666,296,000 after purchasing an additional 208,235 shares during the period. Bank of New York Mellon Corp grew its stake in shares of Walgreens Boots Alliance by 3.0% in the 2nd quarter. Bank of New York Mellon Corp now owns 10,875,615 shares of the pharmacy operator’s stock valued at $652,699,000 after purchasing an additional 320,484 shares during the period. Finally, LSV Asset Management grew its stake in shares of Walgreens Boots Alliance by 17.2% in the 2nd quarter. LSV Asset Management now owns 8,704,233 shares of the pharmacy operator’s stock valued at $522,384,000 after purchasing an additional 1,277,546 shares during the period. 64.57% of the stock is owned by hedge funds and other institutional investors.

Several research firms have recently weighed in on WBA. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, September 21st. TheStreet upgraded Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research note on Wednesday, September 12th. BidaskClub upgraded Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, August 21st. Cowen lowered Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating and set a $104.00 price target on the stock. in a research report on Monday, July 23rd. Finally, Pivotal Research increased their price target on Walgreens Boots Alliance from $60.00 to $72.00 and gave the stock a “hold” rating in a research report on Monday, October 15th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the company. Walgreens Boots Alliance has an average rating of “Hold” and a consensus target price of $78.22.

NASDAQ WBA opened at $82.39 on Friday. The company has a market cap of $77.75 billion, a P/E ratio of 13.61, a price-to-earnings-growth ratio of 1.30 and a beta of 0.74. Walgreens Boots Alliance Inc has a one year low of $59.07 and a one year high of $83.00. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.38 and a current ratio of 0.82.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, topping the Zacks’ consensus estimate of $1.45 by $0.03. The business had revenue of $33.44 billion for the quarter, compared to analyst estimates of $33.64 billion. Walgreens Boots Alliance had a return on equity of 21.75% and a net margin of 3.82%. Analysts forecast that Walgreens Boots Alliance Inc will post 6.54 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 12th. Shareholders of record on Monday, November 12th will be given a $0.44 dividend. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $1.76 dividend on an annualized basis and a yield of 2.14%. Walgreens Boots Alliance’s payout ratio is 29.24%.

In other Walgreens Boots Alliance news, SVP Kimberly R. Scardino sold 11,970 shares of the stock in a transaction on Thursday, November 1st. The stock was sold at an average price of $79.79, for a total value of $955,086.30. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction on Thursday, November 1st. The shares were sold at an average price of $79.48, for a total value of $217,457.28. Following the completion of the transaction, the director now owns 8,207 shares in the company, valued at $652,292.36. The disclosure for this sale can be found here. Insiders sold a total of 66,706 shares of company stock worth $5,268,584 over the last quarter. Corporate insiders own 14.80% of the company’s stock.

WARNING: This piece was posted by American Banking News and is the property of of American Banking News. If you are reading this piece on another website, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece can be read at https://www.americanbankingnews.com/2018/11/10/sompo-japan-nipponkoa-asset-management-co-ltd-purchases-11740-shares-of-walgreens-boots-alliance-inc-wba.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

See Also: How Do You Calculate Return on Equity (ROE)?

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply